Location History:
- Ann Arbor, MI (US) (1993 - 2023)
- Irving, TX (US) (2024)
Company Filing History:
Years Active: 1993-2025
Title: Gary Louis Bolton: Innovating for a Healthier Future
Introduction:
Gary Louis Bolton, a prominent inventor hailing from Ann Arbor, MI, has made significant contributions to the field of drug discovery and development. With a remarkable portfolio of 27 patents and a focus on treating diseases associated with the heat shock protein pathway and inflammation, Bolton's work embodies the spirit of innovation and scientific advancement.
Latest Patents:
Bolton's recent patents highlight his commitment to finding novel solutions for various diseases and disorders. One such patent involves the development of biaryl amides and coumarin-based compounds with modified sugar groups. These compounds, demonstrated by the provided formulas (I), (II), (III), (IV), and (V), exhibit promise in the treatment and prevention of neurological disorders, including neurodegenerative diseases and diabetic peripheral neuropathy.
Additionally, Bolton's patent on pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators signifies his dedication to combating inflammation-related ailments. The compounds described in this patent have the potential to serve as effective treatments for various inflammatory conditions, with formulation, methods, and pharmaceutical compositions included.
Career Highlights:
Bolton's professional journey has been marked by notable collaborations and accomplishments. He has worked with esteemed organizations such as Reata Pharmaceuticals, Inc. and Warner-Lambert Company (now a part of Pfizer Inc.). These companies, renowned for their endeavors in pharmaceutical development, provided Bolton with a platform to contribute his expertise and engage with cutting-edge research.
Collaborations:
Throughout his career, Bolton has had the privilege of working alongside exceptional individuals, further fostering innovation and collaboration. Among his notable coworkers are Xin Jiang and Melean Visnick, whose valuable insights and combined efforts have undoubtedly elevated the quality and impact of their shared projects.
Conclusion:
Gary Louis Bolton's exemplary work in the field of pharmaceutical inventions and patents showcases his relentless pursuit of improving human health. Through his latest patents, he has demonstrated a particular focus on developing treatments for diseases associated with the heat shock protein pathway and inflammation. Bolton's contributions not only lay the foundation for future advancements but also reflect the collaborative efforts within the industry. As we look towards a brighter and healthier future, it is inventors like Gary Louis Bolton who inspire and drive progress in the field of medical innovation.